SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

$SWEAT is the beating heart of the Movement Economy—a groundbreaking token that transforms physical activity into real-world value. Minted through movement, $SWEAT rewards your steps with a crypto asset that you can earn, trade, or grow. The team states that their app has increased their users’ physical activity by an average of 20%, creating a healthier society and reducing burdens on global healthcare systems. With over 20 million holders, SWEAT is eliminating barriers and making Web3 accessible to everyone, one step at a time.

Sweat Economy

Sweat Economy (SWEAT) is trending as a comprehensive token analysis highlights recent scarcity boosts from token burns, its expanding utility as a multi-chain "universal gas token," and growing Web3 gaming features. The community actively discusses its unique "move-to-earn" model, expressing long-term optimism for its potential as a reward for physical activity.

GRAIL, Inc. operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T. Huber, William H. Rastetter, Mostafa Ronaghi, and Richard D. Klausner on September 11, 2015 and is headquartered in Menlo Park, CA.

GRAIL Inc.

GRAIL (GRAL) is sharply trending downwards following news that its NHS-Galleri cancer screening trial missed a primary endpoint, sparking intense community debate between investors who view the significant sell-off as an overreaction given other positive trial data and institutional backing, and those who foresee further declines due to the trial's failure.

Klarna Group Plc is a global digital bank and flexible payments provider. It operates through an AI-powered payments and commerce network that empowers people to pay smarter, with a mission to be available everywhere, for everything. The company was founded by Gustav Erik Niklas Adalberth, Karl Anders Victor Jacobsson, and Sebastian Marcin Siemiatkowski in 2005 and is headquartered in London, the United Kingdom.

Klarna Group plc

Klarna is trending as its stock experiences a steep decline after reporting a loss and providing a weak forecast, despite revenue growth. This has fueled community debate over the viability of its 'Buy Now, Pay Later' business model, with many questioning its path to profitability and the broader fintech sector's credit risk amidst increasing loan loss provisions.

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

Celsius Holdings (CELH) is trending due to a significant after-hours surge following strong growth projections from its CEO at the CAGNY conference and positive commentary on Alani Nu integration during PepsiCo's earnings call. This has intensified community speculation of a future Pepsi acquisition, with bulls highlighting robust market share gains while others debate management's transparency and potential implications of Pepsi's increased board presence.

Newmont Corp. engages in the exploration and acquisition of gold properties, containing copper, silver, lead, zinc or other metals. It operates through the following geographical segments: Canada, Mexico, Suriname, Argentina, Peru, Australia, Papua New Guinea, Ghana, and U.S. The company was founded by William Boyce Thompson on May 2, 1921 and is headquartered in Denver, CO.

Newmont Corp

Newmont is trending after its Q4 earnings beat on revenue, EPS, and delivered record free cash flow. However, mixed reactions to 2026 gold production guidance, higher costs, and the dividend payout have fueled volatile discussions among investors, who are debating whether the dip presents a buying opportunity amid the strong gold market.

NEAR Protocol is the blockchain for AI. A high-performance, AI-native platform built to power the next generation of decentralized applications and intelligent agents. It provides the infrastructure AI needs to transact, operate, and interact across Web2 and Web3. NEAR combines three core elements: User-Owned AI, which ensures agents act in users’ best interests; Intents and Chain Abstraction, which eliminate blockchain complexity for seamless, goal-driven transactions across chains; and a sharded blockchain architecture that delivers the scalability, speed, and low-cost execution needed for real-world AI and Web3 use. This integrated stack makes NEAR the foundation for building secure, user-owned, AI-native applications at internet scale.

Near

NEAR Protocol is currently trending due to its deep integration with AI, highlighted by joining the NVIDIA Inception Program, and advancements in cross-chain capabilities via NEAR Intents. The community is actively discussing its robust fundamentals, recent tokenomics adjustments, and notable institutional interest, including Grayscale's S-1 filing for a NEAR Trust, driving accumulation debates among investors.

Tandem Diabetes Care, Inc. engages in the design, development, and commercialization of products for people with insulin-dependent diabetes. Its products include Tandem Mobi System and t:slim X2 Insulin Pump. The company was founded by Paul M. DiPerna on January 27, 2006 and is headquartered in San Diego, CA.

Tandem Diabetes Care Inc

Tandem Diabetes Care is a focus of discussion following its recent earnings, which generated mixed reactions among the community despite reported beats on some metrics, and is further driven by anticipation for its Control-IQ+ technology and strategic partnerships with Abbott. Many investors see the stock as undervalued given these developments and its efforts to enhance competitiveness in the evolving diabetes management sector.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsoft is trending as a significant insider purchase ignites community belief that the stock is oversold, prompting widespread discussion of a potential rebound driven by its foundational role in the advancing AI and cloud sectors.

Pull your BankrWallet out of the Terminal and into the browser to use with Any Dapp, just like Metamask!

BankrWallet

BankrWallet ($BNKRW) is trending due to the recent launch of its open-source browser extension, offering MetaMask-like functionality within the Coinbase BASE ecosystem and live on Solana. The community is actively discussing its significant upside potential, with many urging early investment ahead of anticipated catalysts, including developer Apoorveth's upcoming discussions.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending as the community eagerly anticipates the BLA resubmission for its Duchenne Muscular Dystrophy therapy, Deramiocel, expected by month-end after strong Phase 3 data. Investors are noting increasing institutional interest and potential regulatory shifts, positioning the stock as a compelling, undervalued biotech play amidst broader market rotations.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Insider Selling: Solid Biosciences (NASDAQ:SLDB) CEO Sells 16,644 Shares of Stock

Solid Biosciences Inc. (NASDAQ:SLDB - Get Free Report) CEO Alexander Cumbo sold 16,644 shares of Solid Biosciences stock in a transaction that occurred on Wednesday, February 18th. The stock was sold...

Insider Selling: Solid Biosciences (NASDAQ:SLDB) Director Sells 2,658 Shares of Stock

Solid Biosciences Inc. (NASDAQ:SLDB - Get Free Report) Director Ilan Ganot sold 2,658 shares of Solid Biosciences stock in a transaction on Wednesday, February 18th. The stock was sold at an average...

Paul Herzich Sells 3,616 Shares of Solid Biosciences (NASDAQ:SLDB) Stock

Solid Biosciences Inc. (NASDAQ:SLDB - Get Free Report) CTO Paul Herzich sold 3,616 shares of the firm's stock in a transaction that occurred on Wednesday, February 18th. The stock was sold at an...

Solid Biosciences (NASDAQ:SLDB) Insider Jessie Hanrahan Sells 4,134 Shares

Solid Biosciences Inc. (NASDAQ:SLDB - Get Free Report) insider Jessie Hanrahan sold 4,134 shares of Solid Biosciences stock in a transaction that occurred on Wednesday, February 18th. The stock was...

David Howton Sells 7,469 Shares of Solid Biosciences (NASDAQ:SLDB) Stock

Solid Biosciences Inc. (NASDAQ:SLDB - Get Free Report) COO David Howton sold 7,469 shares of Solid Biosciences stock in a transaction dated Wednesday, February 18th. The stock was sold at an average...

Insider Selling: Solid Biosciences (NASDAQ:SLDB) CEO Sells $96,868.08 in Stock

Solid Biosciences Inc. (NASDAQ:SLDB - Get Free Report) CEO Alexander Cumbo sold 16,644 shares of the company's stock in a transaction on Wednesday, February 18th. The stock was sold at an average...

Solid Biosciences (NASDAQ:SLDB) CFO Kevin Tan Sells 5,404 Shares

Solid Biosciences Inc. (NASDAQ:SLDB - Get Free Report) CFO Kevin Tan sold 5,404 shares of the firm's stock in a transaction on Wednesday, February 18th. The stock was sold at an average price of...

Solid Biosciences Highlights FDA Path for SGT-003 DMD Study, Shares Early Friedreich's Ataxia Update

Solid Biosciences (NASDAQ:SLDB) used a presentation at the 2026 Emerging Outlook Biotech Summit to outline its gene therapy-focused pipeline and discuss recent regulatory interactions around its lead...

Needham & Company LLC Reaffirms Buy Rating for Solid Biosciences (NASDAQ:SLDB)

Needham & Company LLC reiterated a "buy" rating and issued a $16.00 price objective on shares of Solid Biosciences in a report on Monday...

Solid Biosciences (NASDAQ:SLDB) CEO Sells $314,999.72 in Stock

Solid Biosciences Inc. (NASDAQ:SLDB - Get Free Report) CEO Alexander Cumbo sold 48,913 shares of Solid Biosciences stock in a transaction on Wednesday, February 4th. The shares were sold at an...

Solid Biosciences, Inc. is a life science company, which engages in the development of treatments for patients with Duchenne muscular dystrophy. It also focuses on developing treatments for neuromuscular and cardiac diseases. The company was founded by Ilan Ganot, Andrey J. Zarur, Matthew Bennett Arnold, Annie Ganot, and Gilad David Hayeem in March 2013 and is headquartered in Charlestown, MA.

Current Price	$5.88
Prev Close	$5.92
Open	$5.81
Dividend Yield	0.00%
50-Day Moving Average	$5.95
Beta	1.83
Avg. Volume	1.04M
PE Ratio	-2.37

52-Week High	$7.37
52-Week Low	$2.41
Market Capitalization	$461.23M
EPS (Annual)	-$3.06
Price to Book	2.12
Revenue Per Employee	$0.00

SLDB
Solid Biosciences Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest SLDB News

SLDBSolid Biosciences Inc